Michele Columbo, MD
General Practice · Bryn Mawr, PANPI 1538151220
Payments from drug & device makers
Across 1,041 payments — averaging $121.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$49K
- Regeneron$47K
- Takeda Pharmaceuticals U.S.A., Inc.$6K
- GSK$5K
- AstraZeneca$3K
- Biocryst US Sales Co., LLC$2K
- plus $15K from 37 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$126,460 in reported general payments places this provider in the 95th percentile of 3,208 general practice providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other general practice in Bryn Mawr
- Corey AnolikPhiladelphia$2.1M
- Richard NagelbergPlymouth Meeting$1.4M
- Alan AtlasPhiladelphia$486K
- Susan McMahonPittsburgh$364K
- Yooson KimMorgantown$316K
- Carl MedgausMonroeville$192K
- Michael WollockArdmore$113K
- Barry BartusiakWashington$104K
- Marc ManosPhiladelphia$85K
- Robert MarusYardley$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.